126 related articles for article (PubMed ID: 9827227)
1. Ras activation in astrocytomas and neurofibromas.
Guha A
Can J Neurol Sci; 1998 Nov; 25(4):267-81. PubMed ID: 9827227
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
Feldkamp MM; Lau N; Guha A
Oncogene; 1999 Dec; 18(52):7514-26. PubMed ID: 10602510
[TBL] [Abstract][Full Text] [Related]
3. Proliferation of human malignant astrocytomas is dependent on Ras activation.
Guha A; Feldkamp MM; Lau N; Boss G; Pawson A
Oncogene; 1997 Dec; 15(23):2755-65. PubMed ID: 9419966
[TBL] [Abstract][Full Text] [Related]
4. Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras.
Feldkamp MM; Lau N; Rak J; Kerbel RS; Guha A
Int J Cancer; 1999 Mar; 81(1):118-24. PubMed ID: 10077162
[TBL] [Abstract][Full Text] [Related]
5. Aberrant G protein signaling in nervous system tumors.
Woods SA; Marmor E; Feldkamp M; Lau N; Apicelli AJ; Boss G; Gutmann DH; Guha A
J Neurosurg; 2002 Sep; 97(3):627-42. PubMed ID: 12296648
[TBL] [Abstract][Full Text] [Related]
6. Expression and regulation of neuropilin-1 in human astrocytomas.
Ding H; Wu X; Roncari L; Lau N; Shannon P; Nagy A; Guha A
Int J Cancer; 2000 Nov; 88(4):584-92. PubMed ID: 11058875
[TBL] [Abstract][Full Text] [Related]
7. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors.
Guha A; Lau N; Huvar I; Gutmann D; Provias J; Pawson T; Boss G
Oncogene; 1996 Feb; 12(3):507-13. PubMed ID: 8637706
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3'-kinase and MAPK/ERK kinase 1/2 differentially regulate expression of vascular endothelial growth factor in human malignant astrocytoma cells.
Woods SA; McGlade CJ; Guha A
Neuro Oncol; 2002 Oct; 4(4):242-52. PubMed ID: 12356354
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
10. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.
Rak J; Mitsuhashi Y; Bayko L; Filmus J; Shirasawa S; Sasazuki T; Kerbel RS
Cancer Res; 1995 Oct; 55(20):4575-80. PubMed ID: 7553632
[TBL] [Abstract][Full Text] [Related]
11. 16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells.
D'Angelo G; Martini JF; Iiri T; Fantl WJ; Martial J; Weiner RI
Mol Endocrinol; 1999 May; 13(5):692-704. PubMed ID: 10319320
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway.
Feldkamp MM; Angelov L; Guha A
Surg Neurol; 1999 Feb; 51(2):211-8. PubMed ID: 10029430
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
Friedrich RE; Beer C; Glatzel M; Hagel C
Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
[TBL] [Abstract][Full Text] [Related]
15. Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.
Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A
Am J Pathol; 1999 Feb; 154(2):581-90. PubMed ID: 10027415
[TBL] [Abstract][Full Text] [Related]
16. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.
Miao H; Wei BR; Peehl DM; Li Q; Alexandrou T; Schelling JR; Rhim JS; Sedor JR; Burnett E; Wang B
Nat Cell Biol; 2001 May; 3(5):527-30. PubMed ID: 11331884
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia.
Maity A; Pore N; Lee J; Solomon D; O'Rourke DM
Cancer Res; 2000 Oct; 60(20):5879-86. PubMed ID: 11059786
[TBL] [Abstract][Full Text] [Related]
19. Activation of VEGF and Ras genes in gastric mucosa during angiogenic response to ethanol injury.
Jones MK; Itani RM; Wang H; Tomikawa M; Sarfeh IJ; Szabo S; Tarnawski AS
Am J Physiol; 1999 Jun; 276(6):G1345-55. PubMed ID: 10362637
[TBL] [Abstract][Full Text] [Related]
20. Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas.
Bian XW; Du LL; Shi JQ; Cheng YS; Liu FX
Anal Quant Cytol Histol; 2000 Jun; 22(3):267-74. PubMed ID: 10872046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
